Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

DNA constructs encoding HIV-1 genes induce cellular cytotoxicity in humans

June 15, 1998

Data safety monitoring board recommends continuation of Remune phase III trial

June 15, 1998

DuPont Merck seeks FDA approval for Sustiva

June 12, 1998

CNI-H0294, an anti-HIV agent with a unique mechanism of action

June 11, 1998

Novopharm Biotech completes patient enrollment for GPI-2A phase Ia trial

June 10, 1998

Cel-Sci's improved AIDS vaccine recognizes most prevalent strains of virus

June 8, 1998

FDA gives VaxGen the go-ahead for phase III testing of AIDSVAX; trials will begin this month

June 4, 1998

Reticulose stimulates immune system in HIV-infected patients

June 2, 1998

Steroidogenesis Inhibitors seeks Romanian approval to begin pediatric trial with Anticort

June 1, 1998

New HIV protease inhibitors disclosed by Merck & Co.

May 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...